- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04763694
Dynamic Change in Accommodation After Wearing Multifocal Soft Contact Lenses for Myopia Control
February 18, 2021 updated by: Xiaoying Zhu, State University of New York College of Optometry
The purpose of this study is to report the changes in accommodation, aberrations, and myopia in patients wearing multifocal soft contact lens for various durations.
The study objectives are to:
- Determine the effects of wearing multifocal soft contact lens on accommodation and aberrations over a 12-month period.
- Determine the effect of wearing multifocal soft contact lens on myopia over a 12-month period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10036
- State University of New York
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 17 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 8-17 years
- Refractive error: Sphere ≤ -10.00D, Cylinder ≤ 1.00D
- Monocular BCVA 20/25 or better
- No previous CL experience required
Exclusion Criteria:
- History of ocular pathology, binocular vision anomalies, refractive surgery, previous myopia control therapy, pharmaceutical agent known to affect accommodation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment arm
Subjects wore multifocal soft contact lenses for 12 months.
|
Myopic subjects wore multifocal soft contact lenses for 12 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Axial length
Time Frame: 12 months
|
Change in axial length over the duration of the study
|
12 months
|
|
Refractive error
Time Frame: 12 months
|
Change in refractive error over the duration of the study
|
12 months
|
|
Accommodation
Time Frame: 12 months
|
Accommodation at various distances during the study
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Phoria
Time Frame: 12 months
|
The amount of horizontal phoria (in prism diopter) at near while the subjects wore multifocal soft contact lenses, measured using Modified Thorington
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Stewart Bloomfield, PhD, State University of New York College of Optometry
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Actual)
December 5, 2020
Study Completion (Actual)
December 5, 2020
Study Registration Dates
First Submitted
February 11, 2021
First Submitted That Met QC Criteria
February 18, 2021
First Posted (Actual)
February 21, 2021
Study Record Updates
Last Update Posted (Actual)
February 21, 2021
Last Update Submitted That Met QC Criteria
February 18, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRBNET ID 1325316
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Multifocal soft contact lenses
-
University of HoustonCompleted
-
Alcon ResearchTerminatedPresbyopia | Astigmatism | Myopia | HyperopiaUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchTerminated
-
Aston UniversityCollege of OptometristsCompletedHyperopia | Amblyopia | AnisohyperopiaUnited Kingdom
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Alcon, a Novartis CompanyCompletedRefractive Error
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Aller, Thomas A., ODJohnson & Johnson Vision Care, Inc.CompletedMyopia | Esophoria | Fixation Disparity